WIN-2299

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
WIN-2299
WIN-2299.svg
Names
Preferred IUPAC name
2-(Diethylamino)ethyl cyclopentyl(hydroxy)(thiophen-2-yl)acetate
Identifiers
  • 15421-88-2 checkY
  • 3737-35-7 (HCl) checkY
3D model (JSmol)
ChemSpider
ECHA InfoCard 100.035.835 Edit this at Wikidata
EC Number
  • 239-435-8
  • InChI=1S/C17H27NO3S/c1-3-18(4-2)11-12-21-16(19)17(20,14-8-5-6-9-14)15-10-7-13-22-15/h7,10,13-14,20H,3-6,8-9,11-12H2,1-2H3
    Key: ASXBIKGZCPZCAN-UHFFFAOYSA-N
  • InChI=1/C17H27NO3S/c1-3-18(4-2)11-12-21-16(19)17(20,14-8-5-6-9-14)15-10-7-13-22-15/h7,10,13-14,20H,3-6,8-9,11-12H2,1-2H3
    Key: ASXBIKGZCPZCAN-UHFFFAOYAH
  • O=C(OCCN(CC)CC)C(O)(C1CCCC1)C2=CC=CS2
Properties
C17H27NO3S
Molar mass 325.47 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

WIN-2299 is an anticholinergic drug.[1] Human reactions to WIN-2299 include sedation (2 mg), LSD-like reactions (6 mg), and an acute delirious episode (10 mg).[2]

References[edit]

  1. ^ Luduena, FP; Lands, AM (1954). "An investigation of the pharmacological actions of three potent antispasmodic compounds and their corresponding metho-salts". The Journal of Pharmacology and Experimental Therapeutics. 110 (3): 282–92. PMID 13143475.
  2. ^ Pennes, HH; Hoch, PH (1957). "Psychotomimetics, clinical and theoretical considerations: Harmine, Win-2299 and nalline". The American Journal of Psychiatry. 113 (10): 887–92. doi:10.1176/ajp.113.10.887. PMID 13402982.